to page content
to site navigation
As a general partner at MDV, Michael Goldberg leverages valuable entrepreneur and investor experience from his more than 25 years of work in the life sciences industry including biotechnology, pharmaceuticals, health
services and healthcare information technology. In addition to pursuing life sciences investments for MDV he works to extend the firm's reach into major universities and research centers. Prior to joining MDV Michael was Managing Director
of Jasper Capital and Co-chair of the California Research and Cures Coalition ($3 billion Prop 71 stem cell campaign). He has also held senior management and operations roles including serving as Chairman of OnCare, an oncology practice
management company he founded in 1995. Until 1999 he also served as OnCare's Chief Executive Officer, where he guided revenue growth to $100 million in three years. Previously, Michael was Founder and Chief Executive Officer of Axion Inc.,
a cancer-focused healthcare service company he started in 1987 and sold to Bristol-Myers Squibb in 1996. Axion ranked number four on Inc. Magazine's list of the 500 fastest growing private companies in America for the five years ended
1994. Michael was also a recipient of Inc. Magazine's 1995 Entrepreneur of the Year Award. Prior to his tenure with Axion, Michael was a partner in the venture capital firm Sevin Rosen Funds, where he was responsible for the firm's
investments in the biomedical industry. Michael received a B.A. from Brandeis University and an M.B.A. from Stanford Graduate School of Business.
Michael Goldberg, General Partner at Mohr Davidow Ventures and Founder of Axion Inc., shares lessons learned through his 25 years of experience as an entrepreneur and investor in the life sciences industry.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.